ESG
Chiesi champions new inhaler propellant to reduce carbon footprint
Chiesi also purchased carbon credits to compensate for the emissions for its entire UK portfolio of respiratory medicines.
Chiesi also purchased carbon credits to compensate for the emissions for its entire UK portfolio of respiratory medicines.